May 8, 2017 / 8:12 PM / 2 months ago

BRIEF-Achaogen reports Q1 loss per share $0.93

1 Min Read

May 8 (Reuters) - Achaogen Inc

* Achaogen reports first quarter 2017 financial results and provides corporate update

* Q1 loss per share $0.93

* Q1 earnings per share view $-0.54 -- Thomson Reuters I/B/E/S

* Achaogen Inc - plazomicin registration activities on track; nda submission planned for second half of 2017

* Achaogen Inc - plan to initiate a phase 1 c-scape clinical trial program in Q2 of 2017

* Achaogen Inc - contract revenue totaled $7.5 million for Q1 of 2017 compared to $5.8 million for same period of 2016. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below